Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4104455 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL829630 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL9720673 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL829291 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL829172 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL830178 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL829553 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL679835 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL98075 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL4092007 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12331228-B2 | Photocurable resin composition, cured product, and laminated body | THREEBOND CO., LTD. (JP) | 2025-06-17 | — | — | US | claimed |
| EP-3417892-B1 | BLOOD PROCESSING FILTER | ASAHI KASEI MEDICAL CO LTD (JP) | 2025-04-02 | — | — | EP | claimed |
| CN-113196171-B | Curable resin composition, dry film, cured product, and electronic component | 太阳控股株式会社 | 2024-04-23 | — | — | CN | claimed |
| US-11560475-B2 | Photocurable resin composition, cured product, and laminate | THREEBOND CO., LTD. (JP) | 2023-01-24 | — | — | US | claimed |
| US-20210122938-A1 | PIGMENT DISPERSION COMPOSITION, CURABLE COMPOSITION, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED PRODUCT | RICOH COMPANY, LTD. (JP) | 2021-04-29 | — | — | US | claimed |
| CN-107229188-B | Photosensitive resin composition | 东友精细化工有限公司 | 2020-10-09 | — | — | CN | claimed |
| CN-105785720-B | Photosensitive resin composition, photocured pattern formed therefrom, and image display device having the same | 东友精细化工有限公司 | 2020-02-07 | — | — | CN | claimed |
| US-9970850-B2 | Sheet of colloidal crystals immobilized in resin, method of displaying structural color using same, method for detecting unevenness distribution or hardness distribution of subject using same, and structural color sheet | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2018-05-15 | — | — | US | claimed |
| US-9970749-B2 | Sheet of colloidal crystals immobilized in resin, method of displaying structural color using same, method for detecting unevenness distribution or hardness distribution of subject using same, and structural color sheet | FUJI KAGAKU CORPORATION (JP) | 2018-05-15 | — | — | US | claimed |
| EP-3032299-B1 | SHEET OF COLLOIDAL CRYSTALS IMMOBILIZED IN RESIN, METHOD FOR DISPLAYING STRUCTURAL COLOR USING SAME, METHOD FOR DETECTING UNEVENNESS DISTRIBUTION OR HARDNESS DISTRIBUTION OF SUBJECT USING SAME, AND STRUCTURAL COLOR SHEET | FUJI KAGAKU CORP (JP) | 2017-05-03 | — | — | EP | claimed |
| US-20090227568-A1 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | HANANJA EHF (IS) | 2009-09-10 | — | — | US | claimed |
| US-20080275030-A1 | alkoxy-polyethylene glycol or (ethylene oxide)1-10 adduct of methanol, ethanol, propanol, isopropanol and cyclopropanol; benzodiazepine; midazolam as a liqid therapeutic agent; less irritation to mucosal membrane when administered through Mucosal; enhances solubility of drug | IKANO THERAPEUTICS, INC. (FORMERLY KNOWN AS "INTRANASAL THERAPEUTICS, INCORPORATED") | 2008-11-06 | — | — | US | claimed |
| WO-2008089426-A2 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | HANANJA EHF (IS) | 2008-07-24 | — | — | WO | claimed |
| EP-1898853-A2 | EPITHELIAL DELAMINATING DEVICE (V) AND BLADES USEFUL IN THAT DEVICE | Tissue Engineering Refraction, Inc. (US) | 2008-03-19 | — | — | EP | claimed |
| WO-2006116601-A2 | EPITHELIAL DELAMINATING DEVICE (V) AND BLADES USEFUL IN THAT DEVICE | TISSUE ENGINEERING REFRACTION INC. (US) | 2006-11-02 | — | — | WO | claimed |
| US-6656595-B2 | Applicable to water-based paint/automotive finish | KANSAI PAINT CO., LTD. (JP) | 2003-12-02 | — | — | US | claimed |
| US-20030129535-A1 | Photosensitive thermosetting resin composition | NAN YA PLASTICS CORPORATION (TW) | 2003-07-10 | — | — | US | claimed |
| US-20020077411-A1 | Pigment dispersing resins | KANSAI PAINT CO., LTD. (JP) | 2002-06-20 | — | — | US | claimed |
| EP-1197537-A2 | Pigment dispersing resins | KANSAI PAINT CO., LTD. (JP) | 2002-04-17 | — | — | EP | claimed |
| EP-0176777-B1 | LIGHT CURABLE DENTAL COMPOSITION | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1989-11-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227568-A1 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT | TMEM205, NUP205, PIGS | MEN1 832/4885KMT2A 3911/4885TSHR 2833/4885 |
| US-20080275030-A1 | alkoxy-polyethylene glycol or (ethylene oxide)1-10 adduct of methanol, ethanol, propanol, isopropanol and cyclopropanol; benzodiazepine; midazolam as a liqid therapeutic agent; less irritation to mucosal membrane when administered through Mucosal; enhances solubility of drug | OPRD1, DRD2, DRD1 | MEN1 3906/4885KMT2A 2581/4885TSHR 2673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.